FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients 12 years and older.
Morgan Ebert, Managing Editor
Advertisement
Morgan Ebert is managing editor of Contemporary OB/GYN® and Contemporary Pediatrics®. She joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio, before joining the Contemporary brands. You can reach her at mebert@mjhlifesciences.com.
Articles by Morgan Ebert, Managing Editor
Increasing daily sit-to-stand transitions lowered diastolic blood pressure in postmenopausal women, offering a simple strategy to support heart health.
A recent survey reveals significant gaps in public knowledge about pregnancy health, including misconceptions on weight gain, supplements, and vaccine safety.
Preconception hypoglycemia is linked to increased risks of preterm birth, low birth weight, and birth defects, a new study from China finds.
Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.
SARS-CoV-2 infection during pregnancy alters placental gene expression and increases pathology, especially when contracted in the first trimester.
A new ACOG clinical guidance offers updated recommendations on umbilical cord management for preterm births based on recent evidence and analysis.
"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.
Kephera Diagnostics announced the launch of EndomTest, a noninvasive blood test for endometriosis, promising faster diagnoses and improved patient care.
Study finds USPSTF guidelines label 89% of pregnancies as at risk for preeclampsia, but moderate risk factors offer limited value in guiding aspirin use.
Experts debate the risks and benefits of SSRIs during pregnancy, emphasizing the need for better education and transparency in treatment options.
Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.
Nearly one-third of women with premature ovarian insufficiency experience depressive symptoms, according to a recent study.
Research reveals significant treatment gaps for hepatitis C in postpartum women and children, highlighting urgent needs for improved care access and awareness.
Women with endometriosis-related infertility are more likely to conceive than those with other causes of infertility, a 30-year study shows.
A pro-inflammatory maternal diet during pregnancy was linked to a 16% higher risk of type 1 diabetes in offspring, Danish cohort study finds.
A roundup of the most impactful FDA approvals in women’s health from January through June 2025, spanning diagnostics, therapeutics, and at-home care.
A look back at the most important FDA approvals, clinical research, and expert perspectives shaping ob-gyn care in the first half of 2025.
Take a quick look at everything you may have missed during Q2 of 2025, including the latest FDA approvals, top stories, and exclusive interviews.
Take a quick look at everything you may have missed last month, including the latest FDA updates and top stories.
Oral sulopenem (ORLYNVAH; Iterum Therapeutics) was non-inferior to amoxicillin/clavulanate for treating uUTIs in women, per the phase 3 REASSURE trial.
Wildfire smoke and heat stress before and early in pregnancy raise the risk of SGA births, especially in climate-vulnerable neighborhoods.
Higher third-trimester glucose levels in insulin-dependent pregnancies are tied to increased obesity risk in adult offspring, a 40-year study finds.
In a recent study, prenatal PFAS exposure was linked to higher adolescent blood pressure, with stronger effects in boys and children born to non-Hispanic Black mothers.
The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.
A recent study found that women with colorectal cancer face an increased long-term risk of pain during sex, early menopause, and pelvic disease.
Childhood adversity may raise endometriosis risk, with exposure to violence linked to a twofold increase, a Swedish study finds.
Daily trimethoprim–sulfamethoxazole in pregnancy reduced preterm births, especially in women with HIV, but did not significantly affect birth weight.
New 14-gene test allows early, precise assessment without partner samples.
Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
DARE to PLAY sildenafil cream becomes commercially available for women in select states
2
Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea
3
High costs and transfusions linked to acute heavy menstrual bleeding
4
FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea
5
